Almac

Almac expands Asia Pacific operations

Wednesday, March 12, 2014 02:58 PM

Global CDMO Almac has expanded its clinical services and technologies capabilities in Asia. The company has established regional hubs in Singapore and Japan to better enable the industry’s growing need to conduct clinical trials in Asia and manage global trials from the region. Local teams will design, implement and manage drug supply strategies and efficient technology solutions throughout the life of each study. 

More... »

WIRB Copernicus Group

Genomic Health, Almac collaborate on test to predict chemotherapy benefits

Wednesday, November 27, 2013 11:50 AM

Genomic Health, a provider of genomic-based diagnostic tests, will exclusively license Almac Group’s technology and intellectual property to further develop, validate and subsequently commercialize a multi-gene test to predict benefit from DNA damage-based chemotherapy drugs, such as the commonly used anthracycline-based regimens, in breast cancer.  Such a test would be particularly useful for high-risk breast cancer patients who are eligible for chemotherapy based on their Oncotype DX score. 

More... »


Richard Segiel, Jr. joins Almac as vice president of U.S. business development

Thursday, October 31, 2013 10:00 AM

Richard Segiel, Jr. has joined Almac’s clinical services business unit as vice president of business development for the U.S. He will focus on developing new business, maintaining existing business and developing partnerships.

More... »

Almac launches SupplyTraQ technology solution

Wednesday, September 25, 2013 03:13 PM

Almac has launched SupplyTraQ, a web-based drug accountability and reconciliation tool that improves clinical trial drug supply management and simplifies post-trial administration. Compatible with IXRS, the company’s IVR/IWR technology, SupplyTraQ enables users to capture drug supply data in real-time and improve the accuracy of the supply management process. 

More... »

Almac launches TruSight tumor profiling next-generation sequencing service

Wednesday, September 11, 2013 01:37 PM

Almac has launched a tumor profiling service running Illumina’s next-generation sequencing (NGS) TruSight Tumor panel as part of their biomarker discovery, development and delivery solutions.

More... »

Almac partners for cancer research in Northern Ireland

Friday, September 6, 2013 02:42 PM

Almac Discovery has announced a $20.2million partnership with the Center for Cancer Research and Cell Biology (CCRCB) at Queen’s University Belfast (QUB) to accelerate cancer-focused drug discovery in Northern Ireland.

More... »

Almac expands, to create 229 jobs

Wednesday, June 12, 2013 02:12 PM

Craigavon-based Almac has announced a commercial manufacturing expansion. With the recent completion of a non-GMP drug development facility at the Craigavon site, this expansion represents a total investment of $10.3 million, including financial support from Invest Northern Ireland.  Up to 229 jobs will be created across both projects over the next three years.

More... »

Almac to host clinical trial workshop series

Wednesday, March 20, 2013 11:06 AM

The Almac Group is hosting its third international series of complimentary workshops this spring, titled “Protocol to Patient: Managing Clinical Supplies in an Evolving Marketplace.”

More... »

Almac’s new U.S. commercial packaging operations pass FDA inspection

Wednesday, February 6, 2013 09:16 AM

Global service provider Almac has passed FDA inspection of its new U.S. commercial packaging operations located in Audubon, Penn. The inspection took place on Jan. 9 and 10, 2013, from which the regulatory body concluded that the site is fully compliant with Good Manufacturing Practices, with no 483 issued.

More... »

Almac completes Knowledge Transfer Partnership with Queens University

Wednesday, January 23, 2013 10:28 AM

Global service provider Almac has successfully completed the Knowledge Transfer Partnership (KTP) with Queens University Belfast, to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis business. 

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs